Pharmanutra Pharmanutra Stock: price and insider trades · Italy

Pharmanutra Pharmanutra is a Health Care company. Its directors and officers file their transactions with Consob. Over the twelve months to 26 October 2026, 7 filings were filed, from 7 insiders.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Over the last twelve months, not one insider purchase of Pharmanutra Pharmanutra stock was filed. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19).

Across the 216 companies tracked on its exchange, the median is 3 filings; at 7 filings, this issuer sits above that mark.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. This summary is built from Consob disclosures alone and does not predict where the share price will go.